DICHIARA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.484
EU - Europa 2.079
AS - Asia 1.338
AF - Africa 251
SA - Sud America 194
Continente sconosciuto - Info sul continente non disponibili 194
OC - Oceania 8
Totale 6.548
Nazione #
US - Stati Uniti d'America 2.409
IT - Italia 785
SG - Singapore 658
RU - Federazione Russa 561
CN - Cina 346
DE - Germania 222
BR - Brasile 166
CI - Costa d'Avorio 155
IE - Irlanda 134
FI - Finlandia 109
VN - Vietnam 108
FR - Francia 69
KR - Corea 62
GB - Regno Unito 52
CA - Canada 50
BD - Bangladesh 35
ES - Italia 35
SN - Senegal 33
IN - India 24
JP - Giappone 24
NG - Nigeria 24
UA - Ucraina 24
HK - Hong Kong 20
SE - Svezia 14
ID - Indonesia 13
PL - Polonia 13
IQ - Iraq 12
NL - Olanda 12
ZA - Sudafrica 11
CZ - Repubblica Ceca 10
AR - Argentina 9
CL - Cile 9
BE - Belgio 7
KE - Kenya 7
MX - Messico 7
TR - Turchia 7
BJ - Benin 6
GR - Grecia 6
AU - Australia 5
JM - Giamaica 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AT - Austria 4
EC - Ecuador 4
HU - Ungheria 4
CH - Svizzera 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
LT - Lituania 3
NZ - Nuova Zelanda 3
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.355
Città #
Singapore 421
Dallas 376
Chandler 295
Santa Clara 287
Moscow 281
San Jose 192
Munich 187
Catania 174
Ashburn 158
Abidjan 155
Chicago 143
Dublin 133
Hefei 81
Helsinki 81
Beijing 65
Seoul 61
Civitanova Marche 60
Los Angeles 55
Boardman 54
Lauterbourg 42
Naples 39
Ho Chi Minh City 35
Cambridge 34
Lawrence 34
Dakar 33
New York 33
Rome 33
Andover 31
Nanjing 28
Council Bluffs 27
Hanoi 26
Milan 25
Bremen 21
Des Moines 21
Buffalo 20
Hong Kong 20
Tokyo 20
Toronto 20
Houston 19
Palermo 19
São Paulo 18
Denver 17
Jacksonville 17
Montreal 16
Phoenix 16
Cuneo 15
The Dalles 14
Brooklyn 13
Lagos 13
Orem 13
Columbus 12
Jyväskylä 12
Madrid 12
Messina 11
Poplar 11
Centro 10
London 10
Warsaw 10
Florence 9
Jakarta 9
Johannesburg 9
Abuja 8
Brno 8
Lappeenranta 8
Sala Baganza 8
Atlanta 7
Cagliari 7
Hebei 7
Mascalucia 7
Pozzallo 7
San Francisco 7
Santiago 7
Shenyang 7
Stockholm 7
Wilmington 7
Bari 6
Belo Horizonte 6
Changsha 6
Cotonou 6
Da Nang 6
Marseille 6
Nanchang 6
Saint Petersburg 6
Scafati 6
Terrassa 6
Amsterdam 5
Basingstoke 5
Brussels 5
Chennai 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Guangzhou 5
Paris 5
Raffadali 5
Aci Catena 4
Bologna 4
City of London 4
Curitiba 4
Ficarra 4
Totale 4.338
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 299
Composti inorganici [Cap. 6] 276
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 199
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 190
Design and Synthesis of Tetrahydropyrrolo[3,4‐c]Pyrazole Sigma‐1 Receptor Ligands 184
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 179
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 167
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 161
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 159
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 158
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 158
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 155
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 153
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 147
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 143
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 141
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 139
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 138
CNS permeability parameters determination through a statistical analysis driven approach 134
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 133
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 131
Development of NO-releasing sigma receptor hybrids as anticancer agents 131
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 130
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 130
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 128
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 127
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 126
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 125
Sigma-2 receptor ligands QSAR model dataset 125
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 122
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 120
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 119
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 117
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 117
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 117
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 116
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 112
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 106
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 98
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 95
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 91
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 87
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 84
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 82
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 79
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 79
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 76
Repurposing of human kinase inhibitors in neglected protozoan diseases 75
H2S releasing molecules in pharmaceutical development 70
DESIGN AND SYNTHESIS OF NOVEL, STRUCTURALLY SIMPLIFIED σ/HDAC DUAL-TARGET PRODRUGS 20
Totale 6.548
Categoria #
all - tutte 19.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022301 0 39 26 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/20251.602 55 214 56 125 221 200 201 105 163 82 92 88
2025/20262.901 181 145 442 215 399 650 263 56 180 166 94 110
2026/202787 80 7 0 0 0 0 0 0 0 0 0 0
Totale 6.548